Medicare Enrolled

Dr. Charles Crane, M.D.

Ophthalmology · South Orange, NJ
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Consulting-driven
71 2ND ST, South Orange, NJ 07079
9737632203
In practice since 2005 (20 years)
NPI: 1710961917 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Crane from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Crane? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Crane

Dr. Charles Crane is an ophthalmology specialist in South Orange, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Crane performed 1,804 Medicare services across 1,318 unique beneficiaries.

Between the years covered by Open Payments, Dr. Crane received a total of $56,180 from 41 pharmaceutical and/or device companies across 326 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Crane is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 1,804 Medicare services $56,180 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,804
Medicare services
Bottom 41% in NJ for ophthalmology
1,318
Unique beneficiaries
$105
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~90 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
706 $94 $142
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
238 $51 $72
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
208 $27 $42
Ultrasound scan to determine eye length and lens power
An ultrasound procedure used to measure the length of the eye and calculate the power of the lens.
126 $45 $65
Cataract surgery with lens implant
Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision.
105 $456 $628
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
99 $104 $169
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
97 $32 $46
Laser removal of recurring cataract
A laser procedure to remove a recurring cataract within the lens capsule.
92 $257 $367
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
85 $65 $102
Slit lamp examination of the eye
This procedure uses a specialized microscope to examine the front portion of the eye.
34 $30 $46
Complex cataract removal with lens implant
A surgical procedure to remove a cataract from the eye and insert an artificial lens to restore vision.
14 $630 $809
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.8% high complexity
23.9% medium
70.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$56,180
Total received (2018-2024)
Avg $8,026/year across 7 years
Top 4% in NJ for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
326
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$42,943 (76.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,285 (18.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,952 (5.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$20,365
2023
$1,099
2022
$28,192
2021
$693
2020
$1,435
2019
$1,633
2018
$2,762

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Glaukos Corporation
$19,213
Johnson & Johnson Surgical Vision, Inc.
$208
ABBVIE INC.
$193
Bausch & Lomb Americas Inc.
$156
RxSight Inc
$148
SUN PHARMACEUTICAL INDUSTRIES INC.
$123
Tarsus Pharmaceuticals, Inc.
$114
Harrow Eye, LLC
$57
Alcon Vision LLC
$31
Sight Sciences, Inc.
$29
Oyster Point Pharma, Inc.
$21
BIOTISSUE HOLDINGS INC.
$19
Amgen Inc.
$19
Dompe US, Inc.
$19
Ocular Therapeutix, Inc.
$16
Top 3 companies account for 96.3% of 2024 payments
All-time payments by company (2018-2024) ›
GLAUKOS CORPORATION
$23,729
Glaukos Corporation
$20,344
BioTissue Holdings, Inc.
$3,091
Bausch & Lomb, a division of Bausch Health US, LLC
$1,325
Allergan, Inc.
$1,315
Johnson & Johnson Surgical Vision, Inc.
$893
Alcon Laboratories Inc
$868
Alcon Vision LLC
$780
Allergan Inc.
$658
Bausch & Lomb Americas Inc.
$488
BIOTISSUE HOLDINGS, INC.
$290
ABBVIE INC.
$277
Sight Sciences, Inc.
$270
NEW WORLD MEDICAL,INC.
$170
AbbVie Inc.
$155
RxSight Inc
$148
SUN PHARMACEUTICAL INDUSTRIES INC.
$138
Novartis Pharmaceuticals Corporation
$116
Tarsus Pharmaceuticals, Inc.
$114
Oyster Point Pharma, Inc.
$109
Merz North America, Inc.
$91
Sun Pharmaceutical Industries Inc.
$89
Kala Pharmaceuticals, Inc.
$74
Aerie Pharmaceuticals, Inc.
$72
NOVARTIS PHARMACEUTICALS CORPORATION
$62
Genentech USA, Inc.
$61
Horizon Therapeutics plc
$60
Harrow Eye, LLC
$57
Shire North American Group Inc
$55
Eyevance Pharmaceuticals LLC
$34
TissueTech, Inc.
$31
Ocular Therapeutix, Inc.
$30
EYEVANCE PHARMACEUTICALS LLC
$30
Merz Pharmaceuticals, LLC
$25
Thea Pharma Inc.
$25
BIOTISSUE HOLDINGS INC.
$19
Amgen Inc.
$19
Dompe US, Inc.
$19
MERZ NORTH AMERICA, INC.
$19
Rayner Intraocular Lenses Limited
$15
Mallinckrodt LLC
$15
Top 3 companies account for 84.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ALPHAGAN P · AcrySof IQ PanOptix · AcrySof IQ PanOptix UV IOL · BESIVANCE · BROMSITE · BromSite (bromfenac ophthalmic solution) 0.075% · CEQUA · CEQUA (cyclosporine ophthalmic solution) 0.09% · COMBIGAN · Catalys Laser System · Centurion · Cequa · Clareon · CyPass · DEXTENZA · DUREZOL · DURYSTA · EYSUVIS · Flarex · IACCESS · IC-8 Apthera IOL · INVELTYS · ISTENT INJECT W · ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM · Kahook Dual Blade · LOTEMAX GEL · LOTEMAX SM · LUMIGAN · MIEBO · OMNI · OMNI SURGICAL SYSTEM · OMNI(R) SURGICAL SYSTEM (US) · OXERVATE · Omidria · PROKERA · PROLENSA · PanOptix · Photrexa · Prokera · RESTASIS · RESTASIS MULTIDOSE · RXSIGHT CONTACT LENS · RXSIGHT INJECTOR HANDPIECE · ReSTOR · Rhopressa · Rocklatan · Simbrinza · TECNIS IOL · TEPEZZA · TRAVATAN Z · TYRVAYA · TearCare · TearCare SmartLid · Tecnis IOL · Tecnis Simplicity · TobraDex ST · Tobradex ST · VABYSMO · VERITAS Vision System · VEVYE · VUITY · VYZULTA · XDEMVY · XEN GLAUCOMA TREATMENT SYSTEM · XEOMIN · XIIDRA · Xeomin · ZYLET · enVista MX60 IOL · iDose · iSTENT iNJECT TRABECULAR MICRO-BYPASS STENT SYSTEM · iStent infinite Trabecular Micro-Bypass System Model iS3 · iStent inject Trabecular Micro-Bypass Stent System · iStent inject Trabecular Micro-Bypass System · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (76%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 4% for ophthalmology in NJ.

Looking for an ophthalmology specialist in South Orange?
Compare ophthalmologists in the South Orange area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
1,196
Per 100K population
140.0
County median income
$76,712
Nearest hospital
VA NEW JERSEY HEALTH CARE SYSTEM
2.3 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Crane is a mixed practice specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 4% of NJ peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Crane experienced with comprehensive eye exam, established patient?
Based on Medicare claims data, Dr. Crane performed 706 comprehensive eye exam, established patient services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Crane receive payments from pharmaceutical companies?
Yes. Dr. Crane received a total of $56,180 from 41 companies across 326 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Crane's costs compare to other ophthalmologists in South Orange?
Dr. Crane's average Medicare payment per service is $105. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Crane) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →